(Q28265326)

Immunotherapy of allergic disease

21 January 2018

1 reference

Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects

21 January 2018

1 reference

Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge

21 January 2018

1 reference

Allergy and allergic diseases. First of two parts

21 January 2018

1 reference

Allergy and allergic diseases. Second of two parts

21 January 2018

1 reference

Apoptosis in tissue inflammation and allergic disease

21 January 2018

1 reference

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

21 January 2018

1 reference

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

21 January 2018

1 reference

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

21 January 2018

1 reference

Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial

21 January 2018

1 reference

IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy

21 January 2018

1 reference

Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma

21 January 2018

1 reference

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

21 January 2018

1 reference

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

21 January 2018

1 reference

FURTHER OBSERVATIONS ON THE TREATMENT OF HAY FEVER BY HYPODERMIC INOCULATIONS OF POLLEN VACCINE

21 January 2018

1 reference

Isolation of haptenic material from ragweed pollen

21 January 2018

1 reference

Induction of both reaginic and blocking antibodies with a low molecular weight fraction of timothy pollen extract

21 January 2018

1 reference

Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. Homology with cysteine proteases

21 January 2018

1 reference

Peptide-based therapeutic vaccines for allergic and autoimmune diseases

21 January 2018

1 reference

Vaccination with genetically engineered allergens prevents progression of allergic disease.

21 January 2018

1 reference

Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium.

21 January 2018

1 reference

A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma

21 January 2018

1 reference

Grass pollen immunotherapy decreases the number of mast cells in the skin.

21 January 2018

1 reference

Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability

21 January 2018

1 reference

Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes

21 January 2018

1 reference

Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model

21 January 2018

1 reference

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen

21 January 2018

1 reference

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.

21 January 2018

1 reference

Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.

21 January 2018

1 reference

Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells

21 January 2018

1 reference

Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.

21 January 2018

1 reference

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

21 January 2018

1 reference

T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity

21 January 2018

1 reference

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

21 January 2018

1 reference

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

21 January 2018

1 reference

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

21 January 2018

1 reference

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

21 January 2018

1 reference

Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy.

21 January 2018

1 reference

Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

21 January 2018

1 reference

Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy.

21 January 2018

1 reference

Inhibition of IgE-induced activation of human mast cells by IL-10.

21 January 2018

1 reference

CD40 expression by human peripheral blood eosinophils

21 January 2018

1 reference

A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections

21 January 2018

1 reference

Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.

21 January 2018

1 reference

Bee venom allergy in beekeepers and their family members

21 January 2018

1 reference

Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study

21 January 2018

1 reference

SEROLOGICAL EVIDENCE OF IMMUNITY WITH COEXISTING SENSITIZATION IN A TYPE OF HUMAN ALLERGY (HAY FEVER).

21 January 2018

1 reference

Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom.

21 January 2018

1 reference

Molecular characterization of human IgG monoclonal antibodies specific for the major birch pollen allergen Bet v 1. Anti-allergen IgG can enhance the anaphylactic reaction.

21 January 2018

1 reference

Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody

21 January 2018

1 reference

Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity

21 January 2018

1 reference

Effect of transmembrane and cytoplasmic domains of IgE on the IgE response.

21 January 2018

1 reference

21 January 2018

IgG4 breaking the rules

1 reference

Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3

21 January 2018

1 reference

Recombinant allergens for skin testing

21 January 2018

1 reference

Molecular design of allergy vaccines

21 January 2018

1 reference

Alteration of the tertiary structure of the major bee venom allergen Api m 1 by multiple mutations is concomitant with low IgE reactivity

21 January 2018

1 reference

Engineering of hypoallergenic mutants of the Brassica pollen allergen, Bra r 1, for immunotherapy

21 January 2018

1 reference

Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy

21 January 2018

1 reference

Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2.

21 January 2018

1 reference

Hypoallergenic variants of the major latex allergen Hev b 6.01 retaining human T lymphocyte reactivity

21 January 2018

1 reference

A mutant of the major apple allergen, Mal d 1, demonstrating hypo-allergenicity in the target organ by double-blind placebo-controlled food challenge

21 January 2018

1 reference

Recombinant allergens with reduced allergenicity but retaining immunogenicity of the natural allergens: hybrids of yellow jacket and paper wasp venom allergen antigen 5s.

21 January 2018

1 reference

A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination.

21 January 2018

1 reference

Cytokine and Antibody Responses in Birch-Pollen-Allergic Patients Treated with Genetically Modified Derivatives of the Major Birch Pollen Allergen Bet v 1

21 January 2018

1 reference

Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes

21 January 2018

1 reference

A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy.

21 January 2018

1 reference

A chimeric human-cat fusion protein blocks cat-induced allergy

21 January 2018

1 reference

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

21 January 2018

1 reference

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

21 January 2018

1 reference

The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.

21 January 2018

1 reference

X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy

21 January 2018

1 reference

Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.

21 January 2018

1 reference

A novel grass pollen allergen mimotope identified by phage display peptide library inhibits allergen-human IgE antibody interaction.

21 January 2018

1 reference

Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.

21 January 2018

1 reference

Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells

21 January 2018

1 reference

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

21 January 2018

1 reference

Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin

21 January 2018

1 reference

A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity.

21 January 2018

1 reference

Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides.

21 January 2018

1 reference

A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses

21 January 2018

1 reference

Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy

21 January 2018

1 reference

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

21 January 2018

1 reference

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

Design of protective and therapeutic DNA vaccines for the treatment of allergic diseases

21 January 2018

1 reference

Sublingual immunotherapy: a comprehensive review.

21 January 2018

1 reference

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

21 January 2018

1 reference

Immune mechanisms of allergen-specific sublingual immunotherapy

21 January 2018

1 reference

Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites

21 January 2018

1 reference

Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.

21 January 2018

1 reference

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial.

21 January 2018

1 reference

Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma.

21 January 2018

1 reference

Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects

21 January 2018

1 reference

IgE: an immunoglobulin specialized in antigen capture?

21 January 2018

1 reference

Outcomes of allergy to insect stings in children, with and without venom immunotherapy

31 March 2020

1 reference

Allergen-specific immunotherapy with recombinant grass pollen allergens

31 March 2020

1 reference

Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response

31 March 2020

1 reference

Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

31 March 2020

1 reference

Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects

31 March 2020

1 reference

Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy

31 March 2020

1 reference

Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study

31 March 2020

1 reference

The future of antigen-specific immunotherapy of allergy

31 March 2020

1 reference

Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment.

31 March 2020

1 reference

T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies

31 March 2020

1 reference

Tertiary structure and biophysical properties of a major peanut allergen, implications for the production of a hypoallergenic protein

31 March 2020

1 reference

Reduced in vivo allergenicity of Bet v 1d isoform, a natural component of birch pollen

31 March 2020

1 reference

Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens

31 March 2020

1 reference

Treatment of cat allergy with T-cell reactive peptides

31 March 2020

1 reference

Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial

31 March 2020

1 reference

Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial

31 March 2020

1 reference

Specific inhibition of allergic reactions to penicillin in man by a monovalent hapten. I. Experimental immunological and toxicologic studies

31 March 2020

1 reference

B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy

31 March 2020

1 reference

Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.

31 March 2020

1 reference

Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy

31 March 2020

1 reference

Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization

31 March 2020

1 reference

The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine

31 March 2020

1 reference

Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study

31 March 2020

1 reference

Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy

31 March 2020

1 reference

Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis

31 March 2020

1 reference

Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial

31 March 2020

1 reference

Abrogation of reaginic antibodies with modified allergens

31 March 2020

1 reference

Generation of Antigen-Specific Suppressor Cells during Allergy Desensitization

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI1934

1 reference

Consolidated OpenCitations Corpus – April 2017

release_5cqwa7svkbeatndwuqisz2pbka

1961074

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5cqwa7svkbeatndwuqisz2pbka

mapped directly with Wikidata item

24 November 2022

based on heuristic

1961074

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference